We are a research-based specialty
biopharma company determined
to give people all over the world a
longer and better life

We are developing the first vaccine
in the world for protection against
diarrhoea caused by ETEC in both
travellers and endemic populations

We distribute a wide range of
specialty biopharma products with
focus on vaccines and immunoglobulins

Scandinavian Biopharma

Welcome to Scandinavian Biopharma,

We are an entrepreneurial company specialised in global vaccine development, manufacturing, registration and commercialization of biopharmaceutical products. Our team has previously successfully developed, manufactured, registered and globally l[...]
Read more

Scandinavian Biopharma

Scandinavian Biopharma presents the year-end report for 2022 with a 30% growth, record sales and the ETEC vaccine candidate about to enter phase 3

It is with great pleasure that we present another really good year of growth. The figures for the full year 2022 add up to an increase in sales of just over SEK 28 million, equivalent to 30% in organic growth. In total, sales amount to approxima[...]
Read more

R&D

Scandinavian Biopharma

Join us! We are hiring both a Senior Scientist and a Scientist

Join us when we are expanding. We are now looking for both a Senior Scientist and a Scientist with experience and interest in drug development in the late clinical phase.  Join us in our work to give people worldwide a longer and better life. [...]
Read more